Introduction {#s1}
============

The acquisition of differentiated cell identities in a multicellular organism is accompanied by the loss of developmental plasticity. Undifferentiated cells are pluripotent and have the potential to activate diverse categories of genes. As differentiation progresses, cells activate cellular identity-specific genes as well as repress non-identity-specific genes, thereby losing pluripotency and attaining a differentiated state that is restricted. In this work, we aimed to uncover molecules and mechanisms that coordinate identity specification with the restriction of cellular plasticity.

The progressive loss of developmental plasticity in differentiating cells was first observed in pioneering somatic nuclear transplant experiments ([@bib8]; [@bib34], [@bib35]). When nuclei from progressively more differentiated frog intestinal cells were transplanted into enucleated eggs, it was observed that egg cells containing less differentiated nuclei developed into tadpoles more efficiently than eggs containing more differentiated nuclei ([@bib34], [@bib35]). Similar trends have been noted in somatic nuclear transplant experiments performed since ([@bib36]).

Experiments in which transcription factors (TFs) are ectopically expressed in progressively more differentiated cells also demonstrate restriction of plasticity. For instance, in *C. elegans*, the overexpression of myogenic helix-loop-helix TF *hlh-1*/MyoD early in embryonic development leads to the activation of muscle genes in all somatic cells ([@bib26]). However, the ability of *hlh-1* to activate its target genes decreases and is completely lost by the time the embryonic cells are post-mitotic. Similar observations are made when endodermal GATA TFs *end-1* and *elt-7* ([@bib94]), ectodermal GATA TFs *elt-1* and *elt-3* ([@bib31]; [@bib30]; [@bib63]) and pharyngeal FoxA TF *pha-4* ([@bib43]) are ectopically expressed in the worm embryo at different developmental time points. Likewise, the overexpression of pluripotency TFs c-Myc, Klf4, Sox2, and Oct4 in non-terminally differentiated Pro-B cells leads to the formation of iPSCs, but expression in differentiated B lymphocytes does not ([@bib38]). In all of these cases, restriction of plasticity is apparent in the inability of more differentiated cells to activate non-identity-specific genes in response to ectopically expressed TFs.

There is accumulating evidence that gene repression mediated by chromatin structure and organization plays an important role in restricting cellular plasticity ([@bib56]). In *C. elegans* and mice, electron microscopy shows mostly open euchromatin in cells of early embryos and an accumulation of closed heterochromatic regions in differentiated cells ([@bib18]; [@bib52]; [@bib64]). Differentiation is also coupled with changes in covalent histone modifications. These histone modifications, in conjunction with one another and their effector proteins can influence chromatin structure, nucleosome-DNA interactions, as well as accessibility to TFs ([@bib32]; [@bib81]). The presence of activating and repressive chromatin marks can divide the genome of a differentiated cell into genes that can be expressed and not expressed, thereby contributing to restriction of plasticity ([@bib58]).

The repressive histone modifications H3K27me3 and H3K9me3 have been specifically implicated in the loss of plasticity. These marks are generally found in distinct chromatin regions in various species including humans, *Drosophila*, mice, and *C. elegans* ([@bib19]; [@bib24]; [@bib39]). H3K27me3 is enriched on developmentally regulated, cell-type-specific genes ([@bib7]; [@bib24]; [@bib39]; [@bib62]). A correlation between loss of H3K27me3, chromatin compaction, and plasticity has been shown in *C. elegans* embryos. The depletion of H3K27me3 in embryos leads to an extension of the time during which chromatin stays more 'open' and a correlated increase in the window of time during which an ectopically expressed TF, *pha-4*, can activate its target genes in embryonic cells ([@bib89]). In previous studies, we have also shown that loss of H3K27me3 depositing polycomb repressive complex 2 (PRC2) in the germ cells of *C. elegans* leads to a gain of plasticity, as measured by the ability of three different identity-specifying TFs to activate their target genes ([@bib65]). On the other hand, H3K9me3 is enriched at repeat-rich regions which remain repressed in all cell types, but there is accumulating evidence that it is also involved in the repression of cell-type-specific genes ([@bib1]; [@bib23]; [@bib27]; [@bib39]; [@bib53]; [@bib54]; [@bib82]). As for restricting plasticity, it has been observed that removing methyl transferases that deposit H3K9me3 increases the efficiency of fibroblast to iPSC reprogramming ([@bib78]). Furthermore, H3K9me3 is enriched at targets of iPSC-inducing 'Yamanaka' factors that fail to become activated in fibroblasts that do not convert into iPSCs ([@bib78]; [@bib79]).

During differentiation, cells activate identity-specific genes and form active and repressive chromatin landscapes ([@bib55]; [@bib58]). How is the establishment of this chromatin-level organization coordinated with the transcription of identity-specific effector genes? Certain identity-specifying TFs facilitate the formation of active chromatin landscapes at *cis*-regulatory regions that they bind. The binding of these TFs leads to formation of more 'open' euchromatin by facilitating changes in histone modifications and chromatin accessibility ([@bib22]; [@bib45]; [@bib90], [@bib91]). These findings have led to the hypothesis that TFs that activate identity-specific genes might also function as organizers of identity-specific active chromatin ([@bib59]). TFs that regulate the formation of open chromatin landscapes are straight-forward to identify since their loss generally leads to the loss of cellular identity. Much less is known about the organization of heterochromatin that mediates restriction of plasticity. Genetic removal of heterochromatin organizers is not necessarily expected to lead to the derepression (i.e. activation) of numerous non-identity-specific genes under wildtype conditions. However, the loss of heterochromatin organizers might make genes more accessible, so that they can be activated if trans-activators are also present in the cell. For this reason, the ectopic expression of TFs represents an experimental strategy for uncovering mechanisms that regulate heterochromatin organization and plasticity restriction.

In this work, we use a TF overexpression assay to show that cellular identity-specifying TFs also regulate the restriction of cellular plasticity at least partially by directing the formation of repressive chromatin in *C. elegans* neurons. In various animal species, it has been shown that the terminal differentiation of individual neuron types is carried out by one or more TFs called terminal selectors, which activate expression of a variety of identity-specific effector genes whose protein products shape the terminally differentiated state of a cell ([@bib40], [@bib42]). In the absence of these TFs, neurons still migrate properly, extend processes, and acquire a 'generic' neuronal state characterized by the expression of pan-neuronal markers; but these neurons do not express neuron-type-specific genes such as ion channels, neurotransmitters, neurotransmitter receptors, etc. ([@bib40]; [@bib80]). We demonstrate here that terminal selector TFs also function to restrict cellular plasticity. To assay restriction, we have used the overexpression of terminal selector CHE-1, a Zn-finger TF, which is normally only expressed in two glutamatergic ASE sensory neurons and which specifies the identity of these neurons by activating expression of ASE-specific genes ([@bib20]; [@bib65]; [@bib76]; [@bib85]). We show here that if CHE-1 is ectopically expressed during embryonic and early larval development, when cells are dividing and differentiating, it can activate expression of ASE-specific effector genes in many cell types. If CHE-1 is expressed at later stages when all cells have differentiated, it is no longer able to activate ASE effector genes in most cells, showing that they are restricted. We then expressed CHE-1 in wildtype and mutant animals in which terminal selectors of specific neuron types are genetically eliminated to assay whether the cells affected in the terminal selector mutants would remain responsive to CHE-1. We found this to be the case in five of seven terminal selector mutants tested, showing that several terminal selector TFs are required for the loss of plasticity.

To understand the mechanistic basis of the plasticity-restricting function of terminal selectors, we focused on *unc-3*, a COE (Collier/Olf1/Ebf) TF which specifies the identity of cholinergic motor neurons (MNs). We identified an allele of *unc-3* in which cholinergic MNs express identity-specific markers and function normally, yet are still plastic. This finding strongly suggests that even in an otherwise appropriately specified neuron, terminal selector function is required to restrict plasticity. Next, using a LacI/LacO spot assay ([@bib55]; [@bib82]; [@bib89]) to tag transgenic loci, we found that the locus of a reporter of a CHE-1 target gene is less condensed in *unc-3* mutant neurons compared to wildtype neurons, suggesting that terminal selector TFs are required for the formation of identity-specific heterochromatin. We also observe that removal of H3K27me and H3K9me depositing enzymes leads to loss of restriction in otherwise normally differentiated neurons, further emphasizing that chromatin does play a role in restricting plasticity of neurons. While the loss of H3K27 methyltransferase showed an additive effect with *unc-3*, the loss of H3K9 methyltransferases did not modify the *unc-3* phenotype suggesting that correct deposition of H3K9me3 may be downstream of *unc-3* function. Overall, this work demonstrates a novel role for terminal selector-like TFs in coordinating the processes of identity-specific gene activation with restriction of cellular plasticity, the latter being mediated at least partially through the correct organization of chromatin in differentiated cells.

Results {#s2}
=======

Differential ability of CHE-1 to activate target genes {#s2-1}
------------------------------------------------------

In order to gain insights into the mechanisms that restrict plasticity, we probed cellular plasticity in many cell types of *C.elegans* throughout different developmental stages. To this end, we ubiquitously expressed Zn-finger TF CHE-1 at different time points in developing worms. CHE-1 is normally expressed only in the ASEs, two sensory neurons located in the head, and acts as a terminal selector by activating expression of numerous ASE-specific effector genes ([@bib10]; [@bib20]; [@bib70]; [@bib83]; [@bib85]). We used a previously described transgenic worm strain which contains a heatshock inducible promoter driving *che-1* expression (CHE-1^hs^), and a reporter of a CHE-1 target gene, *gcy-5*, that is normally expressed in ASER ([@bib65]; [@bib84]). In this assay, non-ASE cells that activate expression of *gcy-5* in response to CHE-1^hs^ expression are considered plastic, whereas cells that do not activate *gcy-5* expression are considered restricted. In this study, we used several tools to detect the expression of *gcy-5,* including two kinds of transgenic reporters (*gcy-5^prom^::gfp and gcy-5^fosmid^::gfp*), smFISH probes against *gcy-5* mRNA, and an allele of *gcy-5* in which the endogenous locus is tagged with *mNeonGreen* using CRISPR/Cas9-mediated genome engineering ([Figure 1---figure supplement 1A,B,C](#fig1s1){ref-type="fig"}). *gcy-5^prom^::gfp* uses 3.2 kb of regulatory sequences directly upstream of the start codon of the *gcy-5* gene, while the *gcy-5^fosmid^::gfp* contains \~33 kb of DNA surrounding the *gcy-5* locus, which should include all potential *cis*-regulatory regions ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). smFISH and the *mNeonGreen* tagged allele validate the endogenous transcription of *gcy-5*, but because the *mNeonGreen* tagged allele was difficult to detect by standard microscopy, we utilized smFISH for the detection of the endogenous transcript in our CHE-1 misexpression experiments. *gcy-5* is normally expressed in the ASER and RIGL/R neurons. Expression of *gcy-5* in the ASER is *che-1* dependent ([@bib10]; [@bib85]), while expression in the RIG neurons is dependent on *lim-6* ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}), and should not be relevant in CHE-1 overexpression assays.

When CHE-1^hs^ is induced during early embryonic stages (\<300 min), *gcy-5^prom^::gfp* is broadly activated in numerous cells ([Figure 1Aiii](#fig1){ref-type="fig"}). However, these embryos become deformed and arrest, making it difficult to score exactly which and to what extent non-ASE cells are CHE-1-responsive. Induction of CHE-1^hs^ during larval development results in an increasingly restricted activation of *gcy-5,* and the animals retain a normal overall morphology ([Figure 1Aiv--viii](#fig1){ref-type="fig"}). With the exception of a few neurons in the head and tail, cells that express *gcy-5* in response to larval CHE-1^hs^ are those that have just been generated and hence are still differentiating ([Figure 1B](#fig1){ref-type="fig"}). For instance, CHE-1^hs^ induction in the L2/L3 stage activates *gcy-5* in seam cells and ventral nerve cord (VNC) neurons, which are dividing and differentiating at this time. As some VNC neurons are born during embryonic stages, we examined whether VNC cells that activate *gcy-5* at L2 are those that are newly born. To this end, we used a pan-neuronal marker, *rab-3^prom^::rfp*, which is brightly expressed in VNC neurons that were born during embryonic stages, but is dim in cells that are still undergoing differentiation. In these worms, activation of *gcy-5^fosmid^::gfp* after L2 CHE-1^hs^ expression is enriched in *rab-3^low^* cells ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}), showing that cells that are dividing and differentiating are more receptive to CHE-1 than cells that have already differentiated. We also observe that vulval muscle cells, which are dividing and differentiating at the L3 stage are receptive to CHE-1^hs^ at this stage ([Figure 1B](#fig1){ref-type="fig"}). At the L4 and adult stages, when all tissues have differentiated, the only cells that activate *gcy-5^prom^::gfp* in response to CHE-1^hs^ are a handful of neurons and pharyngeal muscle cells, suggesting that these differentiated cells provide some molecular context which makes them amenable to *che-1* activity ([Figure 1Aviii and B](#fig1){ref-type="fig"}). Such context-dependent activity has been previously observed for TF *elt-7,* which when overexpressed, leads to a context-dependent activation of endodermal identity in specific adult tissues ([@bib69], [@bib68]). The CHE-1 responsive neurons include the RIS, CEP, ASK, and ASI neurons. These neurons do not bear any obvious relationship to ASE, and it is unclear why these cells remain responsive to CHE-1.10.7554/eLife.24100.002Figure 1.Expression of ASE markers in response to CHE-1^hs^ at different developmental stages.(**A**) Expression of *gcy-5^prom^::gfp *becomes less broad as CHE-1^hs^ is induced at later stages. (i) L1 worm without CHE-1^hs^, bright expression in ASER; (ii) adult without CHE-1^hs^, expression in ASER (arrow); (iii) embryonic CHE-1^hs^, broad *gcy-5^prom^::gfp* induction in deformed embryos; (iv) L1 CHE-1^hs^,expression of *gcy-5^prom^::gfp* in various tissues including hypodermis, various neurons, muscles, pharynx. (v) L2 CHE-1^hs^ at two different focal points, *gcy-5^prom^::gfp* in seam, muscles, ventral nerve cord, other neurons and pharynx; (vi) L3 CHE-1^hs^, *gcy-5^prom^::gfp* in seam, vulva cells, neurons and pharynx; (vii) L4 and (viii) adult CHE-1^hs^, *gcy-5^prom^::gfp* is seen only in neurons and pharynx. Higher magnification of the heads in (i) and (viii). (**B**) Quantification of the expression of *gcy-5^prom^::gfp* in various tissues after CHE-1^hs^ induction at various ages, as listed on the X-axis. n =\> 20 for each stage. (**C**) Expression of *gcy-6^fosmid^* and *gcy-7^prom^* in response to CHE-1^hs^ at different stages. Quantification of the ectopic expression: every dot in this graph represents a worm and the number on the y-axis represents the total number of marker-expressing neurons counted. Ectopic expression decreases as the age of the embryos being heatshocked increases. (**D**) A synthetic \~300 bp region of the *gcy-5* promoter in which the ASE motif has been multimerized four times can be broadly induced by CHE-1^hs^ at all stages, including L4s, as shown here. Some of the tissues that express *gcy-5^4XASE^::gfp* are labeled. *gcy-5^4XASE^::gfp* is normally expressed only in the two ASEs.**DOI:** [http://dx.doi.org/10.7554/eLife.24100.002](10.7554/eLife.24100.002)10.7554/eLife.24100.003Figure 1---figure supplement 1.Tools used for the detection of *gcy-5* expression.(**A**) Schematic representation of the fosmid and promoter reporters of *gcy-5.* The fosmid contains \~33 kb of DNA surrounding the *gcy-5* locus. A trans-splicing sequence, SL2, and GFP are recombineered after the stop codon of *gcy-5.* This ensures that *gcy-5* and *gfp* get transcribed together but get spliced and translated separately. The promoter reporter contains 3.2 kb of information upstream of the start codon of the *gcy-5* gene fused to *gfp.* (**B**) Images of heads of transgenic neurons containing the *gcy-5^prom^::gfp*, *gcy-5^fosmid^::gfp*, and a CRISPR-engineered allele containing an *SL2::mNeonGreen* inserted into the genomic *gcy-5* locus after the *gcy-5* stop codon. RIG expression of the promoter-based reporter is not fully penetrant. Expression of the CRISPR allele is very dim. Asterisks indicate expression of co-injection marker. (**C**) FISH for *gcy-5* mRNA also shows expression in the ASER and RIG neurons. (**D**) Expression of *gcy-5* in the RIGs is dependent on *lim-6*, not *che-1*. Two RIG neurons can be seen in 100% of the wildtype worms. 0 RIGs can be seen in 100% of *lim-6* mutant worms (n = 20 each). Asterisks indicate expression of co-injection marker.**DOI:** [http://dx.doi.org/10.7554/eLife.24100.003](10.7554/eLife.24100.003)10.7554/eLife.24100.004Figure 1---figure supplement 2.Expression of *gcy-5* in response to CHE-1^hs^ at different developmental stages.(**A**) Expression of *gcy-5^fosmid^* in the VNC after CHE-1^hs^ at L2 is enriched in newly born neurons based on overlap with *rab-3^low^* (born at L2) and *rab-3^high^* (born during embryonic stages). (**B**) Ectopic induction of endogenous *gcy-5* in response to heat-shock. FISH for *gcy-5* mRNA after CHE-1^hs^ induction in MiniMos strain containing a single copy *hs^prom^::che-1* transgene integrated into the genome and *gcy-5^prom^::gfp*. Expression of *gcy-5* mRNA overlaps with *gcy-5^prom^::gfp.* (**C**) *che-1* mRNA induction after heatshock. Heatshock induction results in robust *che-1* mRNA expression at the adult stage. Pictures show smFISH of *che-1* mRNA in heads of adult worms before and after heat-shock. In the absence of heat-shock, a few mRNA molecules can be detected, however after heat-shock the expression is much more robust. (**D**) CHE-1 protein induction after heatshock. The heatshock-induced CHE-1 contains an HA tag. Antibody staining for HA tag shows the presence of protein in all cell types. Mid-bodies of adult worms are shown. No CHE-1::HA protein is detected without heat-shock, while nuclear localized protein is clearly visible after heat- shock. Some tissues, such as hypodermis and muscle, show stronger induction of protein than other tissues.**DOI:** [http://dx.doi.org/10.7554/eLife.24100.004](10.7554/eLife.24100.004)10.7554/eLife.24100.005Figure 1---figure supplement 3.Expression of ASE markers in response to cell type-specific, but not temporally controlled, *che-1* expression.(**A**) For each worm, promoters driving post-mitotic *che-1* expression are listed on the horizontal axis and ASE markers used are listed on the vertical axis. *gcy-5^prom^::gfp, gcy-5^fosmid^::rfp,* and *ceh-36^fosmid^::yfp* are broadly expressed in response to *che-1,* whereas *gcy6^fosmid^::gfp, and gcy-7^prom^::rfp* are not. Some marker, promoter combinations were not determined (n.d.) because of unsuccessful crosses. (**B**) *gcy-5^prom^* is broadly expressed in the hypodermis and (**C**) post mitotic muscles in response to CHE-1 induction in these tissues.**DOI:** [http://dx.doi.org/10.7554/eLife.24100.005](10.7554/eLife.24100.005)

The same pattern of *gcy-5^prom^::gfp* induction is also seen when CHE^hs^ is induced with a single copy *hs^prom^::che-1* transgene generated by MiniMos-mediated genome engineering ([@bib25]). Additionally, *gcy-5* smFISH of these worms shows that expression of *gcy-5^prom^::gfp* overlaps with the expression of endogenous *gcy-5* mRNA, indicating that the endogenous *gcy-5* gene is induced by ectopic CHE-1^hs^ and that the transgene *gcy-5^prom^::gfp* reliably replicates the activity of the endogenous *gcy-5* locus ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}).

We confirmed that the restricted activation of *gcy-5* in adults is not due to an inability to efficiently induce CHE-1^hs^. Ater heatshock induction in adults, both *che-1* mRNA and protein can be detected in all cell types ([Figure 1---figure supplement 2C,D](#fig1s2){ref-type="fig"}). Furthermore, to ensure that the expressed CHE-1 protein is functional, we generated a synthetic strong reporter that contains a 4X multimerized CHE-1 binding site ('ASE motif'), taken from the *gcy-5* locus, driving *gfp.* We find that this *gcy-5^4XASE^::gfp* reporter is expressed broadly, in all somatic cell types at every stage of development, in response to CHE-1^hs^ expression from both the multi-copy and single-copy heatshock-inducible transgenes ([Figure 1D](#fig1){ref-type="fig"}). Therefore, the restricted activation of *gcy-5* reflects the inability of CHE-1^hs^ to activate its target genes in differentiated cells.

To determine the breadth of this phenomenon, we examined expression of two additional *che-1* target genes, *gcy-6 and gcy-7*, in the heatshock assay([@bib10]; [@bib85]). These genes are receptor guanylate cyclases expressed exclusively in the ASEL neuron during normal development ([@bib88]). If CHE-1^hs^ is induced during early embryonic stages, the resulting arrested embryos and larvae activate broad expression of *gcy-6^fosmid^::gfp* and *gcy-7^prom^::rfp.* Expression of these markers also becomes more restricted as CHE-1^hs^ is induced at later stages. However, ectopic induction of these genes is not as broad as *gcy-5* and no ectopic expression is detected when CHE-1^hs^ is induced in larval stages. ([Figure 1C](#fig1){ref-type="fig"}). Previous analysis has shown that while CHE-1 is sufficient to activate ASER-specific genes, it may require other co-activators to activate ASEL-specific genes ([@bib21]; [@bib41]). This may explain the difference in the breadth of ectopic CHE-1 activity.

Since embryonic expression of CHE^hs^ leads to deformation and developmental arrest, we expressed CHE-1 using tissue-specific promoters to understand more thoroughly its activity in various differentiating cell types. We utilized a muscle (*unc-27^prom^*), hypodermal (*dpy-7^prom^*), pan-neuronal (*ric-19^prom^*), and two neuron-type-specific drivers (*unc-47^prom^* expressed in GABAergic MNs, *ift-20^prom^* expressed in sensory neurons). With the exception of the hypodermal promoter, these promoters all become activated only in post-mitotic cells at the time that cells are initiating expression of various identity-specific genes. CHE-1 driven by all neuronal promoters resulted in broad ectopic expression of *gcy-5^prom^::gfp*, *gcy-5^fosmid^::gfp*, and *ceh-36^fosmid^::yfp* (another *che-1* target, a homeodomain TF expressed in ASEL/R and AWC neurons) . However, *gcy-6^fosmid^::gfp* and *gcy-7^prom^::rfp* show restricted activation in only 1--2 extra cells ([Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}). Transgenic animals expressing CHE-1 in the hypodermis or muscle also showed *gcy-5^prom^::gfp* expression in the respective tissues ([Figure 1---figure supplement 3b,c](#fig1s3){ref-type="fig"}). In combination with the heatshock experiments, these experiments show that a wide range of cell types are receptive to CHE-1 activity after post-mitotic division while they are terminally differentiating. Once terminal differentiation is accomplished, most cells lose their multipotency and become refractory to CHE-1 activity.

Terminal selector *unc-3* restricts plasticity of cholinergic motor neurons {#s2-2}
---------------------------------------------------------------------------

Our finding that cells lose their receptivity to ectopically expressed CHE-1 after terminal differentiation led us to hypothesize that the loss of cellular plasticity might be coordinated with the acquisition of a terminal identity. In *C. elegans*, the expression of identity-specific genes in many neurons is established by single or combinations of terminal selector TFs. These TFs are generally expressed after the terminal cell division and are required for both the activation and maintenance of identity-specific effector gene batteries ([@bib40]). In the absence of such TFs, the mutant neurons are born and express numerous pan-neuronal genes that normally get activated at the same time as identity-specific genes, suggesting that multiple aspects of terminal differentiation proceed normally. However, the lack of identity- and function-specific genes which include neurotransmitter synthesis genes, ion channels, etc., indicate that these neurons fail to acquire their neuron-type-specific identity. We asked whether, in addition to specifying identity, these terminal selector TFs might also facilitate the process of restriction, thereby coordinating it with terminal differentiation. If this were the case, in the absence of a terminal selector gene, a cell would remain in a more plastic state, and in our experimental paradigm, retain its receptivity to CHE-1^hs^. Alternatively, if an independent mechanism triggers the restriction of cellular plasticity, cells would lose their receptivity to CHE-1^hs^ regardless of the presence of the terminal selector.

To test these alternative hypotheses, we induced CHE-1^hs^ in *unc-3* mutants. *unc-3* is a COE-type TF that acts as the terminal selector for A/B-type and AS cholinergic MN identity ([@bib50]; [@bib67]). *unc-3(-)* cholinergic MNs are born and found in approximately their wildtype positions in the ventral nerve cord (VNC), retro-vesicular ganglion (RVG), and pre-anal ganglion (PAG) of the worm. They express pan-neuronal identity markers, and form axonal projections. However, these neurons lack expression of all the acetylcholine pathway genes, numerous other terminal identity genes, show defects in synaptogenesis and are non-functional ([@bib50]; [@bib67]). To test if such *unc-3(-)* neurons retain plasticity, we induced CHE-1^hs^ in wildtype and *unc-3* mutant worms at various larval stages and scored the expression of *gcy-5^prom^::gfp* in the RVG, VNC, and PAG. In addition to fifty *unc-3* dependent MNs, these ganglia contain 19 GABAergic MNs and 13 other *unc-3-*independent neurons ([Figure 2A](#fig2){ref-type="fig"}). To decrease the ambiguity in scoring, we used a red fluorescent GABAergic marker in the background and counted the number of *gcy-5-*p*ositive* cells that were non-GABAergic. In wildtype worms, we find that an average of 11 neurons activate *gcy-5^prom^::gfp* at the L2 stage upon ectopic CHE-1^hs^ expression, and this number is reduced to an average of 2 neurons by the L4 and adult stages. In *unc-3* mutants, a significantly higher number of neurons express *gcy-5^prom^::gfp* at every developmental stage upon ectopic CHE-1^hs^ expression ([Figure 2B](#fig2){ref-type="fig"}). *gcy-5^prom^::gfp* expression in the VNC was not seen when *unc-3 *mutants were heatshocked in the absence of the *hs^prom^::che-1* transgene, showing that the loss of *unc-3* is not sufficient for an identity switch. We repeated these experiments using the single copy *heatshock^prom^::che-1* transgene, and again observed that *gcy-5^prom^::gfp* expression is induced in significantly more *unc-3(-)* than wildtype cells. Additionally, smFISH of these worms showed that expression of endogenous *gcy-5* mRNA was also induced in *unc-3(-)* cells to a similar extent ([Figure 2C](#fig2){ref-type="fig"}). On average, about 30% of affected neurons in *unc-3* mutants express *gcy-5* in response to CHE-1^hs^ induction.10.7554/eLife.24100.006Figure 2.Several CHE-1 targets retain their CHE-1 responsiveness in *unc-3* mutant cholinergic MNs.For all heatshock experiments, three biological replicates were performed. The student t-test is used for statistical comparisons, \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, n.s.= p\>0.05. (**A**) A schematic representation of the neurons in the RVG, VNC, and PAG of the worm. In heatshock experiments represented in **B**, **C**, and **D**, the number of ASE marker expressing cells in the RVG, VNC, and PAG were scored. In **B** and **D***, unc-47,* a marker of GABAergic identity (is used in the background and only *unc-47(-)* neurons are scored. This strategy ensures proper scoring of the \~50 *unc-3* dependent cholinergic MNs . (**B**) Images of wildtype and *unc-3* worms with and without CHE-1^hs^ and a quantification of *gcy-5^prom^* induction at various stages of development. Every dot in this plot represents an individual worm. The entire RVG, VNC, and PAG of the worm is scored. A significantly higher number of *gcy-5^prom^::gfp* neurons are seen in *unc-3* mutants as compared to wildtype in response to CHE-1^hs ^induction. No *gcy-5^prom^::gfp* neurons are seen in *unc-3* mutant worms that get heatshocked but do not contain the *heatshock^prom^::che-1* array (0 cells in \>20 worms). (**C**) *gcy-5^prom^* transgene (green bar) and *gcy-5* mRNA (smFISH; pink bar) induction in heatshocked worms carrying a single copy insertion of *heatshock^prom^::che-1.* Induction of *gcy-5* endogenous mRNA (smFISH) is similar to the induction of the *gcy-5^prom^* reporter. (**D**) Expression of various other ASE markers is seen in a significantly higher number of *unc-47(-)* RVG, VNC, and PAG neurons in *unc-3* mutants as compared to wildtype after CHE-1^hs^ induction. The scored markers and their wildtype (without CHE-1^hs^) expression patterns are listed above each plot. Every dot in these plots represents an individual worm. Markers are scored only in the anterior and posterior regions of the worm, as represented in A. These worms were heatshocked at the L4 stage.**DOI:** [http://dx.doi.org/10.7554/eLife.24100.006](10.7554/eLife.24100.006)

To assess the breadth of CHE-1^hs^ activity, we also examined the activation of other CHE-1 target genes in the VNCs of *unc-3* mutants. Genes that showed increased induction after L4 CHE-1^hs^ in *unc-3* included the glutamate transporter *eat-4^fosmid^::yfp,* the homeodomain TF *ceh-36^fosmid^::yfp*, and the ciliary protein *ift-20^prom^::rfp* ([Figure 2D](#fig2){ref-type="fig"}). No induction of *gcy-6^fosmid^::gfp* or *gcy-7^prom^::rfp* was observed in wildtype or *unc-3(-)* neurons, which is consistent with the idea that *che-1* is not sufficient for the induction of these genes, as discussed earlier (0 neurons induced in \>20 worms checked). As the transgenic markers that show increased induction in *unc-3(-)* neurons are randomly integrated into the different chromosomes of the worm, this phenotype suggests that several regions of the genome remain receptive to CHE-1^hs^ activity in the mutant condition.

*unc-3* is required broadly for activation of both generic and sub-type-specific cholinergic MN identity features. The further diversification of cholinergic MNs into sub-types is controlled by the activity of various class-specific repressors, such as paired homeodomain TF *unc-4*, the nuclear receptor TF *unc-55*, and the T-box TF *mab-9* ([@bib49]; [@bib57]; [@bib66]). The loss of these TFs results in MNs with mixed class identities and subsequent functional defects. We asked if these repressor TFs also contribute to the restriction of plasticity. Neither *unc-4* mutants, nor *unc-55; mab-9* double mutants, however, show increased induction of *gcy-5^prom^::gfp* in cholinergic MNs in response to CHE-1^hs^ ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). These data demonstrate that a disruption of function and identity-specific transcriptional programs does not automatically make cells more plastic.

Restriction of cellular plasticity is a function shared by several terminal selectors {#s2-3}
-------------------------------------------------------------------------------------

We examined the expression of *gcy-5* in response to adult CHE-1^hs^ after removal of six other terminal selectors that control the identity of a wide range of different neuron types in the head and tail ganglia of the worm. Four of the six mutants showed a phenotype similar to *unc-3* in that their removal allowed ectopic, CHE-1^hs^-dependent *gcy-5* expression. These terminal selectors are ETS-domain TF *ets-5,* and homeodomain TFs *ttx-1*,* ceh-14*, and *lin-11*. Specifically, *ets-5* is a terminal selector for the CO~2~ sensing BAG neurons ([@bib33]). In our assay, 30% of *ets-5(-)* BAG neurons express *gcy-5^fosmid^::gfp* in response to adult CHE-1^hs^ as opposed to 4% of wildtype BAG neurons ([Figure 3A](#fig3){ref-type="fig"}). *ttx-1* is a terminal selector for thermosensory AFD neurons ([@bib74]; [@bib76]) and 23% of *ttx-1(-)* AFD neurons express *gcy-5^fosmid^::gfp* after adult CHE-1^hs^ whereas 2% of wildtype AFD neurons do ([Figure 3B](#fig3){ref-type="fig"}). Removing both *ttx-1* and *ceh-14*, the co-factor of *ttx-1* in AFD specification, results in a 34.3% phenotype compared to 4.8% in matched wildtypes. *ceh-14* also acts as a terminal selector in several distinct tail neuron classes [@bib76]). We found an average increase of five *gcy-5^fosmid^*-positive neurons in the tails of *ceh-14* mutants upon CHE-1 induction ([Figure 3C](#fig3){ref-type="fig"}). Lastly, *lin-11* is required for terminal identity specification of ASG neurons ([@bib76]), and 30% of *lin-11(-)* ASG neurons express *gcy-5^fosmid^::gfp* as opposed to 2% of wildtype ASG neurons ([Figure 3d](#fig3){ref-type="fig"}).10.7554/eLife.24100.007Figure 3.Several distinct terminal selectors control restriction of cellular plasticity in distinct neuron types.CHE-1^hs^ was induced in adults for all experiments except *lin-11*, for which L4s were heatshocked (*lin-11 *mutant adults are very short-lived due to internal hatching of progeny). The markers in red are used to help identify the neuron of interest. *gcy-5^fosmid^::gfp* is more frequenctly activated by CHE-1^hs^ in BAG neurons of *ets-5* mutants (panel A), in AFD neurons of *ttx-1* mutants (panel B), in DVC and a few other unidentifiable neurons in the tail of *ceh-14* mutants (panel C), and in ASG neurons of *lin-11* mutants (panel D). All error bars represent SEM. Data are accumulated from three independent heatshock experiments. The student t-test is used, \*\*\*p\<0.0001, n.s.= p\>0.01.**DOI:** [http://dx.doi.org/10.7554/eLife.24100.007](10.7554/eLife.24100.007)10.7554/eLife.24100.008Figure 3---figure supplement 1.Phenotypes of additional mutants.CHE-1^hs^ was induced in adults for all experiments. Every dot in (A) and (B) represents an individual worm. The student t-test is used for statistical comparisons, \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, n.s.= p\>0.05. (**A**) *mab-9;unc-55* double mutants and *unc-4* mutants are not significantly different from wildtype and are significantly different from *unc-3*. (**B**) The phenotype in the AFD neurons remains partially penetrant in *ttx-1; ceh-14* double mutants, similar to *ttx-1* single mutants. (**C**) An increase of *ceh-36^fosmid^::yfp* expression is seen in 2 neurons in *unc-30* compared to wildtype worms in *unc-30* mutants. As there are 19 total *unc-30* dependent neurons, this difference does not seem biologically significant. Every dot in the graph represents an individual worm. (**D**) No *gcy-5^fosmid^::rfp* expression is seen in the ASH neurons of *unc-42* mutants. (**E**) *gcy-5^4XASE^::gfp* can be induced in wildtype GABAergic neurons after CHE-1^hs^ induction in adults, showing that CHE-1^hs^ is functional in these neurons. (**F**) *gcy-5^4XASE^::gfp* can also be induced in wildtype ASH neurons after CHE-1^hs^ induction in adults. All error bars represent SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.24100.008](10.7554/eLife.24100.008)

Two terminal selector mutants, the homeodomain TFs *unc-30* and *unc-42,* did not share this phenotype. *unc-30* is the terminal selector for GABAergic MNs in the VNC and *unc-42* is the terminal selector for ASH sensory neurons ([@bib3]; [@bib11]; [@bib48]; [@bib76]). No increases in induction of *gcy-5^prom^::gfp* or *ceh-36^fosmid^::yfp* were detected in response to CHE-1^hs^ in the GABAergic MNs of *unc-30* ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}, data only shown for *ceh-36^fosmid^::yfp*). In the case of *unc-42 *mutants, neither *gcy-5^fosmid^::rfp*, nor *ceh-36^fosmid^::yfp* was detected in the ASH neurons after CHE-1 misexpression ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}, data only shown for *gcy-5^fosmid^::rfp*). Expression of *che-1* early in the development of GABAergic MNs and ASH neurons does lead to activation of target genes, based on tissue-specific promoter driven expression of *che-1* ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). Additionally, activation of CHE-1^hs^ in L4s/adults results in the expression of *gcy-5^4XASE^::gfp* in both sets of neurons ([Figure 3---figure supplement 1E,F](#fig3s1){ref-type="fig"}). This means that CHE-1 is competent to activate target genes in these neurons while they are differentiating, and that its activity as a TF is uncompromised in these neurons during the adult stage. Therefore, we conclude that while *unc-30* and *unc-42* are required for terminal differentiation, they are dispensable for restricting cellular plasticity.

Overall, these results suggest that numerous terminal selector genes play a role in restricting the activity of ectopically expressed CHE-1. The affected neurons in all these TF mutants lack expression of certain identity-specific effector genes. The negative results with *unc-30* and *unc-42* demonstrate that the loss of a terminal identity in itself it not sufficient to keep a neuron in a plastic state. This suggests that the restriction of plasticity is a distinct and parallel function carried out by certain terminal selector TFs. In the next sections, we provide more evidence that supports this functional distinction.

The identity-specifying and plasticity-restricting functions of UNC-3 can be genetically separated {#s2-4}
--------------------------------------------------------------------------------------------------

Two alternative hypotheses can explain the function of terminal selectors in the restriction of plasticity. Terminal selectors could simply be required for terminal differentiation, and it would be the completion of differentiation that then indirectly triggers restriction of plasticity. Alternatively, these transcription factors could be required for restricting plasticity in a mechanism that is separate from inducing effector genes of terminal cellular identity. A hypomorphic allele of *unc-3* that we inadvertently generated by CRISPR-Cas9 mediated transgenesis allowed us to separate the identity-specifying function from the plasticity-restricting function of *unc-3.* This allele contains an insertion of a plant-specific AID degron into the *unc-3* locus that allows for protein degradation in the presence of exogenous plant hormone auxin and the Arabidopsis F-box protein *TIR1 *([@bib93]) ([Figure 4A](#fig4){ref-type="fig"}). In the absence of TIR1 and auxin, the *unc-3::mNG::AID* worms display wildtype locomotion and express cholinergic MN markers at near wildtype levels ([Figure 4A,B](#fig4){ref-type="fig"}). However, cholinergic MNs of these worms were receptive to CHE-1^hs^, even in the absence of TIR1 and auxin ([Figure 4C,D](#fig4){ref-type="fig"}). When CHE-1^hs^ is overexpressed in adult worms containing *unc-3::mNG::AID*, expression of *gcy-5^prom^::gfp* is observed at a penetrance indistinguishable from that observed in the *unc-3* null allele. Hence, in this allele the cholinergic MNs differentiate largely normally, and yet retain plasticity in response to CHE-1^hs^ activity. This allele therefore supports the hypothesis that terminal selector-like TFs control restriction independently of specification. While it is unclear how the AID allele affects the *unc-3* protein, we propose that this allele results in lower levels of active protein, perhaps by degradation through an auxin/TIR1 independent pathway.10.7554/eLife.24100.009Figure 4.Genetic separation of identity-specification and plasticity restriction.All error bars represent SEM. The student t-test is used, \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, n.s.= p\>0.05. (**A**) An mNeonGreen::AID tagged allele of *unc-3, ot837,* does not have the locomotion defects of an *unc-3* null allele. (**B**) *ot837* worms show near wildtype and wildtype induction of *cho-1^fosmid^* and *acr-2^prom^* respectively, whereas in *unc-3* null mutants these genes are strongly repressed ([@bib50]). *cho-1^fosmid^* expression is missing in \~4 neurons in *ot837*, but levels of expression in the neurons that retain expression look wildtype. (**C**) *ot837* behaves like the *unc-3* null with respect to restriction of plasticity. Induction of *gcy-5^prom^* is indistinguishable in *ot837* and the *unc-3* null allele after CHE-1^hs^ induction. (**D**) Images of *gcy-5^prom^* expression in *ot837* worms after CHE-1^hs^ induction. In these images the nuclear green signal comes from the mNG tagged UNC-3 protein, the cytoplasmic GFP from *gcy-5^prom^* (green arrows), and the red cells are GABAergic (red arrows).**DOI:** [http://dx.doi.org/10.7554/eLife.24100.009](10.7554/eLife.24100.009)

*unc-3* regulates chromatin compaction {#s2-5}
--------------------------------------

We next asked if terminal selectors restrict cellular plasticity by controlling chromatin accessibility at genes that are not expressed in differentiated cells. We focused again on *unc-3* and hypothesized that in the wildtype cholinergic MNs CHE-1 targets would be present in a repressed, inaccessible chromatin state while in *unc-3* mutants they would be present in a more open state, such that they are more likely to be activated by CHE-1. To visualize the chromatin state with single cell resolution, we used a chromosome tagging method that has previously been used to study the localization and state of compaction of transgenic loci in *C. elegans* ([@bib12]; [@bib22]; [@bib55]; [@bib89]). We created a repetitive transgene array containing *gcy-5^prom^::rfp* and bacterial LacO sites and randomly integrated it into the genome. These transgenic worms also carry a separate transgene to ubiquitously express a LacI::GFP fusion protein. Thus, in every nucleus of this worm, LacI::GFP binds to the LacO sites surrounding the *gcy-5* reporter, thereby labeling the *gcy-5* transgenic loci as two green dots ([Figure 5A,B](#fig5){ref-type="fig"}). We also generated LacO arrays for an *unc-3*-dependent cholinergic gene, *ace-2^prom^::rfp,* as a control ([Figure 5C](#fig5){ref-type="fig"}). This technique has previously been used to show a correlation between the compaction state of the LacI::GFP spots and the repressed or active state of the locus in the array ([@bib12]; [@bib22]; [@bib55]; [@bib89]).10.7554/eLife.24100.010Figure 5.Assessing chromatin state of a *gcy-5* transgenic locus with the LacI/LacO dot assay.The student t-test is used for statistical comparisons, \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, n.s.= p\>0.05. (**A**) Schematic representation of the spot assay. A transgene containing the *gcy-5^prom^::rfp* sequence and LacO binding sites is integrated into the genome of worms that ubiquitously express LacI::GFP. In the resulting transgenic worm, every nucleus contains two GFP spots representing the LacI::GFP bound to the *gcy-5* LacO array. The structure and location of this locus can be visualized by GFP. (**B**) The *gcy-5* arrays localize to the nuclear periphery in all cells in which expression was checked, including the ASEs. The array is transcriptionally active in the ASER, as evident by the presence of RFP, suggesting that this locus localizes to the nuclear periphery regardless of its transcriptional state. An identically built *ace-2^prom^::rfp* LacO array shows sub-nuclear localization that correlates to its transcriptional state. In cells that express *ace-2^prom^::rfp,* as seen by the presence of RFP, the GFP spots are diffused and in the nuclear lumen, suggesting that the locus is decompacted. In cells that do not express *ace-2^prom^::rfp,* the GFP spots are compact and localized to the nuclear periphery. Two independent array integrants examined for both *ace-2 *and *gcy-5* showed similar results and one is shown here. (**C**) Worms were fixed and stained with DAPI for quantification of the GFP spots as an estimation of array structure. (**D**) *ace-2* arrays were significantly larger when transcriptionally active as opposed to inactive in the VNC neurons of wildtype worms compared to *unc-3* mutants. In (**D, E, F**) each dot represents a single nucleus and the number on the y-axis is the total pixel count occupied by the LacI/O spots or H3K27me3 per neuron. (**E**) *gcy-5* arrays were significantly larger in *unc-3* mutant neurons than in wildtype. (**F**) Control staining for H3K27me3 in *gcy-5 LacO* array containing worms showed no difference between wildtype and *unc-3* and the size of the *gcy-5* LacI/O spots do not change in the hypodermal nuclei of wildtype vs. *unc-3* worms.**DOI:** [http://dx.doi.org/10.7554/eLife.24100.010](10.7554/eLife.24100.010)

To facilitate quantification of the state of compaction, wildtype and *unc-3* mutant animals containing the *ace-2* and *gcy-5* LacO arrays were fixed with paraformaldehyde and stained with GFP and DAPI. The total number of GFP pixels per VNC neuron was then calculated as an approximation of the space occupied by the *ace-2* and *gcy-5* LacO transgenes in wildtype and *unc-3* mutant neurons. This quantification was performed blinded. The *ace-2* LacO array is transcriptionally active in wildtype cholinergic neurons but not in *unc-3* mutants ([Figure 5B,C](#fig5){ref-type="fig"}). Consistent with its expression, the *ace-2* LacO array showed a significantly higher GFP pixel count in wildtype VNC neurons as compared to *unc-3* ([Figure 5C,D](#fig5){ref-type="fig"}). By showing that the *ace-2* transgenic locus is more open when it is transcriptionally active, this experiment indicated that the LacI/O dot assay is indeed indicative of the state of chromatin in cholinergic MNs. We then quantified GFP spots on the LacO array that contains *gcy-5*, the ASE-specific CHE-1 target gene that is normally not expressed in VNC MNs. In this case, the size of the GFP spot was increased in *unc-3* mutant MNs compared to wildtype ([Figure 5E](#fig5){ref-type="fig"}). These data show that the *gcy-5* locus is in a less compact state in *unc-3* mutant cholinergic MNs, which may make it more amenable to activation by CHE-1. This change in compaction was not as dramatic as the one observed in the *ace-2* array, but this may be because while the *ace-2* array is actively transcribed in wildtype neurons, the *gcy-5* array is not being actively transcribed in *unc-3* mutants, rather it is simply in a more accessible state so that it is more likely to be transcribed when CHE-1 is ectopically induced. The quantified worms were also co-stained with H3K27me3 to control for staining efficiency and we did not observe a significant change in the number of H3K27me3 pixels between wildtype and *unc-3* in the same neurons ([Figure 5F](#fig5){ref-type="fig"}).

If the change in compaction of the *gcy-5* array were caused by *unc-3* function, this change should be specific to neurons in which *unc-3* acts as a terminal selector. Indeed, the size of the *gcy-5* LacO array in hypodermal cells of wildtype and *unc-3* mutants show no statistically significant difference ([Figure 5F](#fig5){ref-type="fig"}). It is also important to note that not all VNC neurons contain larger GFP spots, which is consistent with the variability we observe in the number of cells per worm that activate *gcy-5* in response to CHE-1 ([Figure 5E](#fig5){ref-type="fig"}, [Figure 2B](#fig2){ref-type="fig"}).

Interplay between *unc-3* and chromatin modifiers in regulating the restriction of plasticity {#s2-6}
---------------------------------------------------------------------------------------------

To confirm and further understand the role of chromatin compaction in our restriction assay, we probed the function of H3K27me and H3K9me. Both of these modifications are associated with silent and condensed chromatin ([@bib82]; [@bib89]).

We have previously shown that the removal of the *C. elegans* PRC2 complex, which functions as an H3K27methyl transferase, makes germ cells more plastic and receptive to CHE-1 activity ([@bib65]). Here, we tested the activity of CHE-1 in the ventral nerve cord of *mes-2*/E(z) mutants. *mes-2* is the enzyme responsible for the histone methyl transferase activity of PRC2 and is known to be required for H3K27me3 in the *C. elegans* germline at all stages, and in somatic cells during embryonic and early larval stages, but not in the adult ([@bib5]). We found that loss of *mes-2* permits CHE-1^hs^ to induce *gcy-5^prom^::gfp* to the same extent as removal of *unc-3* does ([Figure 6A](#fig6){ref-type="fig"}), indicating that *mes-2* is indeed required for restriction of plasticity in cholinergic MNs. To determine whether *mes-2* acts in parallel or in the same pathway as *unc-3*, we tested *mes-2; unc-3* double mutants and found that they have an additive phenotype. Removal of both *unc-3* and *mes-2* leads to the induction of *gcy-5^prom^::gfp* in twice as many cells as seen in *unc-3* or *mes-2* mutants alone. This suggests that *unc-3* and *mes-2* work in parallel genetic pathways to ensure plasticity restriction in differentiated cholinergic MNs.10.7554/eLife.24100.011Figure 6.Interactions of *unc-3* with chromatin mutants.CHE-1^hs^ was induced at the L4 stage. For each graph, the data cumulatively represent three independent heatshock experiments in which all genotypes were scored in parallel. Every dot represents an individual worm. One way ANOVA with post-hoc Bonferroni and Scheffé tests for multiple comparisons were performed independently for each group of strains tested together. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, n.s.= p\>0.05. (**A**) *mes-2* mutants show increased induction of *gcy-5^prom^::gfp* in response to CHE-1^hs^ and show an additive phenotype with *unc-3*, suggesting H3K27me3 regulates restriction in a parallel pathway with *unc-3.* The *mes-2* and *unc-4* mutations are genetically linked. *unc-4* does not play a role in restriction, but it was used in all strains tested in this set of experiments to ensure similar genetic backgrounds. (**B**) Both *met-2* and *set-25* mutants have significantly more *gcy-5^prom^::gfp* expressing cholinergic MNs compared to wildtype. However, for *set-25* the increase is only modest, and a *met-2 set-25* double mutant is not significantly different from *met-2,* suggesting *met-2,* has a greater role in making the *gcy-5^prom^::gfp* locus inaccessible to CHE-1. An additive phenotype is not evident in *met-2; unc-3*, *set-25; unc-3*, or *met-2 set-25; unc-3*, suggesting that these factors might act in the same pathway to restrict the accessibility of *gcy-5^prom^::gfp.* No ectopic expression of *gcy-5^prom^::gfp* is seen in these mutants in the absence of CHE-1^hs^ (not shown, n \> 50 worms). (**C**) HP1 mutants also show increased induction of *gcy-5^prom^::gfp,* and slightly enhance the phenotype of *unc-3* suggesting they have roles independent of *met-2 set-25* dependent H3K9me. No *gcy-5^prom^::gfp* is induced in *hpl-1;hpl-2* double mutants in the absence of CHE-1^hs^ (not shown, n \> 50 worms). (**D**) Representative images of scored worms. (**E**) Induction of CHE-1^hs^ with the single copy transgene also results in increased induction of *gcy-5^prom^::gfp* in the VNC of *met-2 set-25* mutants and the number of *gcy-5^prom^::gfp* and *gcy-5* mRNA expression cells in the double mutant worms are similar showing that the phenotype in (**B**) is not simply a result of derepressed repetitive transgenes.**DOI:** [http://dx.doi.org/10.7554/eLife.24100.011](10.7554/eLife.24100.011)10.7554/eLife.24100.012Figure 6---figure supplement 1.H3K9 in wildtype and *unc-3* mutant worms.(**A**) H3K9me3 is not detectable in *met-2 set-25* double mutants at the L4/adult stage (n \> 50 for each). Wildtype worms without *unc-47^prom^::rfp* and double mutant worms containing *unc-47^prom^::rfp* were fixed, stained, and imaged together. (**B**) Mutants of methyl transferases that deposit active histone marks do not show any increased or modified induction of *gcy-5^prom^::gfp* after CHE-1^hs^ induction. (**C**) H3K9me3 staining is detectable in the VNC neurons of wildtype and *unc-3* mutant worms. (**D**) CRISPR engineered fluorescently tagged HPL-1, HPL-2, and MET-2 proteins are detectable in the VNC neurons of wildtype and *unc-3* mutant worms. Yellow arrows point at VNC neuronal nuclei.**DOI:** [http://dx.doi.org/10.7554/eLife.24100.012](10.7554/eLife.24100.012)

To test the role of H3K9me3, we tested the ability of CHE-1^hs^ to activate *gcy-5* in the VNC of cholinergic MNs in *met-2* and *set-25* mutants. *met-2* and *set-25* are SET-domain proteins shown to be required for H3K9 methylation in *C. elegans* embryos, young larvae, and adult germ lines ([@bib82]; [@bib92]). *met-2* mutant embryos lack H3K9me1/2/3 whereas *set-25* embryos lack H3K9me3 ([@bib82]). Using antibody staining, we ensured that *met-2; set-25* double mutants also lack H3K9me3 at the L4 and adult stages where we perform our experiments ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). If H3K9me3 plays a role in decreasing the accessibility of a *gcy-5^prom^::gfp*, then this locus should remain more accessible in *met-2* and *set-25* mutants. We found that induction of CHE-1^hs^ does lead to increased activation of *gcy-5^prom^::gfp* in the cholinergic MNs of *met-2* single mutants and *met-2 set-25* double mutants, but not in *set-25* single mutants ([Figure 6B](#fig6){ref-type="fig"}). This suggests that H3K9me1/2 and H3K9me3 have to be perturbed for CHE-1^hs^ to activate *gcy-5^prom^::gfp*. H3K9me3 is known to be involved in the repression of repetitive loci. To ensure that our phenotype is not an artifact of repetitive transgenes, we confirmed that the loss of *met-2; set-25* in transgenic worms containing the single copy *hs::che-1* transgene also results in the expression of *gcy-5^prom^::gfp* in the cholinergic MNs and that the expression of *gfp* in these worms overlaps with *gcy-5* mRNA expression as determined by smFISH of endogenous *gcy-5* transcripts ([Figure 6E](#fig6){ref-type="fig"}).

To test genetic interactions between *unc-3*, *met-2* and *set-25* we examined CHE-1^hs^ dependent induction of *gcy-5^prom^::gfp* in *met-2;unc-3*, *set-25;unc-3* and *met-2 set-25;unc-3* double and triple mutants. None of these double and triple mutants show an additive effect that is significantly different from the phenotype of *unc-3* single mutants ([Figure 6B](#fig6){ref-type="fig"}), indicating that *met-2, set-25,* and *unc-3* act in the same pathway rather than in parallel pathways. Since the removal of *met-2* and *set-25* does not result in as strong a phenotype as an *unc-3* single mutant, we furthermore infer that *met-2;set-25* dependent H3K9 methylation is not the only pathway affected in the *unc-3* mutants.

To investigate the mechanisms of H3K9 action further, we considered HP1, a conserved chromodomain containing protein that is known to bind methylated H3K9 ([@bib2]; [@bib47]; [@bib46]; [@bib51]; [@bib60]). The *C. elegans* genome encodes two homologs of HP1, *hpl-1* and *hpl-2* ([@bib13]; [@bib75]). *hpl-1* has been shown to colocalize with H3K9me3 in embryos by immunofluorescence, and *hpl-2* shows enriched binding at H3K9me1/2 regions by whole embryo ChIP analysis ([@bib27]; [@bib86]). Fluorescent-tagged HPL-1 and HPL-2 proteins localize to distinct foci on chromatin and these proteins seem to have both unique and redundant functions ([@bib75]). We asked if mutants of these proteins phenocopy the loss of *met-2* and *unc-3* in MNs after CHE-1^hs^ expression. Indeed, an increased induction of *gcy-5^prom^::gfp* was seen in MNs after removal of both *hpl-1* and *hpl-2*, and this phenotype was enhanced in the double mutant, so that it was stronger than the phenotype of *met-2 set-25* mutants ([Figure 6c](#fig6){ref-type="fig"}). An *hpl-2; hpl-1 unc-3* triple mutant also shows a phenotype that is enhanced from the *hpl-1; hpl-2* double or the *unc-3* mutant alone, but it is not completely additive. This enhancement indicates that HP1 has functions independent of *met-2 set-25* and H3K9me. Induction of *gcy-5* in all of the mutants tested here required CHE-1^hs^ induction. Taken together, both H3K9me and H3K27me contribute to the restriction of plasticity in differentiated cells. H3K9me might be acting along with terminal selectors to mediate this process, while H3K27me acts in parallel ([Figure 7](#fig7){ref-type="fig"}).10.7554/eLife.24100.013Figure 7.A model for the role of terminal selectors in restriction of plasticity.Grey indicates lack of protein activity. In wildtype neurons, *unc-3* activates expression of target genes to specify cholinergic MN identity but it also triggers the restriction of plasticity by activating pathways that repress genes not required for cholinergic MN identity. The repressed genes include ASE effector genes, which cannot be activated by ectopic CHE-1 in wildtype MNs. To restrict plasticity, *unc-3* may regulate the correct distribution of H3K9 methylation through unknown pathways and may also activate additional repressors (R). These repressor mechanisms may then act to \'survey\' the genome for genes that have not been activated during identity specification and transform them into a \'non-activatable\' stage via H3K9-dependent heterochromatinization. *unc-3* is required to trigger this surveillance mechanism by controlling the function or expression of the genes involved in this process. Independently, *mes-2*-dependent H3K27 methylation also plays a role in gene silencing. Upon lowering levels of *unc-3 *activity (*ot837* allele) activation of cholinergic MN genes still takes place, however the *unc-3* dependent pathways that repress other identity genes are not activated, as shown by the ability of CHE-1 to activate its target genes. When *unc-*3 is absent, neither specification nor restriction takes place so that cholinergic MN specific genes are not expressed and CHE-1 targets can be activated. A loss of both *unc-3* and *mes-2* results in even more open chromatin, and an increased activation of CHE-1 target genes.**DOI:** [http://dx.doi.org/10.7554/eLife.24100.013](10.7554/eLife.24100.013)

We hypothesized that perhaps in *unc-3* mutants, a reduction of histone modifications that are associated with active chromatin marks at *unc-3-*induced terminal differentiation genes might be causing a titration of negative histone marks over the genome, thereby increasing accessibility at genes that would otherwise have high levels of negative marks like H3K9me3. It has, for example, been observed that removal of positive mark H3K36 trimethylation leads to a titration of H3K27me3 from loci that are normally repressed ([@bib28]). However, genetic removal of positive histone marks like H3K4me3 and H3K3me3 did not result in enhanced cellular plasticity ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}).

Further attempts to understand how *unc-3* might regulate H3K9me have not yet been successful. First, *hpl-1, hpl-2*, and *met-2* gene expression is unaffected in *unc-3* mutants ([Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}). Second, H3K9me3 can be detected in both wildtype and *unc-3 *animals by immunostaining ([Figure 6---figure supplement 1D](#fig6s1){ref-type="fig"}). A third possibility is that the distribution of H3K9me3 over the genome may be affected in *unc-3* mutant cholinergic MNs. We attempted to test this hypothesis by performing co-localization assays between the *gcy-5 LacO* transgene and H3K9me3, MET-2::mKATE2, or HPL-1/2::mKATE2 in wild-type and *unc-3* deficient MNs. However, these tools were not sufficiently sensitive to answer this question. H3K9me3 localization at the *gcy5* LacO array could not be quantified as the structure of the array was not well preserved after the H3K9me3 staining procedure (Materials and Methods). MET-2 and HPL-1/2 localization could not be quantified because of low expression levels in neurons. Therefore, it remains to be seen if terminal selectors like *unc-3* regulate the correct deposition of H3K9me or if they regulate other functions mediated by *met-2* and HP1 to make non-identity defining genes less accessible.

Discussion {#s3}
==========

Differentiated cells are defined by identity-specific transcriptional programs that are stably maintained throughout the life of a cell ([@bib6]; [@bib14]). Here, we provide evidence that in *C. elegans* neurons, identity-defining terminal selectors not only initiate and maintain the expression of effector genes that define a cellular phenotype but they also trigger the restriction of cellular plasticity. We propose that the coordination of identity specification and restriction of plasticity ensures the robustness of the differentiated state, protecting cells from accidental transcription of unwanted genes in response to fluctuations in the environment ([@bib87]).

Differentiation and the restriction of cellular plasticity {#s3-1}
----------------------------------------------------------

The loss of developmental plasticity in differentiating cells can be experimentally demonstrated as a cell's inability to respond to ectopically expressed TFs. To assay plasticity, we have ubiquitously expressed a terminal selector TF, CHE-1, at various developmental time points in *C. elegans* and scored its ability to activate fluorescent reporters of target genes. CHE-1 is normally expressed only in 2 ASE sensory neurons where it activates an ASE-specific gene battery. We found that cells that are dividing and beginning to acquire lineage and identity-specific markers are receptive to the activity of ectopic CHE-1. Once cells are postmitotic, they remain receptive for a limited window of time while they are activating terminal identity genes, and then become refractory. A progressive loss of ectopic TF activity in postmitotic cells has also been reported in the mouse brain. Fezf-2, a master regulatory gene for corticospinal MNs, is capable of activating target genes in embryonic and early postnatal callosal projection neurons and retains its ability to act at postmitotic day 3 and 6. However, this ectopic activity progressively declines and is exhausted by day 21 ([@bib71]). These data show that a change occurs in differentiated post-mitotic cells that makes non-identity-specific genes less likely to get activated. In this work, we find that this change is triggered by the resident terminal selector of the differentiated cells in conjunction with downstream and parallel chromatin changes.

We found that the loss or reduction of terminal selector TF activity keeps some neurons in a more plastic state. Five of seven terminal selectors tested in our CHE-1^hs^ assay are required in distinct neuron types to make genes normally expressed in ASE neurons inaccessible to ectopically expressed CHE-1, suggesting that the coordination of differentiation and restriction of cellular plasticity is a commonly occurring phenomenon. The difference between TFs that do and do not function to restrict plasticity is not clear. The two terminal selector-depleted cell types that do not respond to CHE-1 are not lineally more distant from ASE neurons than the five terminal selector mutant cell types that do respond to CHE-1. A comprehensive expression profile of some of these neurons in the presence and absence of the respective TFs may resolve the mechanistic basis for this difference.

In mice, the terminal selector Pax5, which is required for the differentiation of B lymphocytes, also functions to restrict cellular plasticity. Non-terminally differentiated Pro-B cells are responsive to the pluripotency TFs c-Myc, Klf4, Sox2, and Oct4 and can be converted into iPSCs but differentiated B lymphocytes are refractory to the activity of these TFs. Pax5 mutant B lymphocytes, on the other hand, can be converted into iPSCs by the activity of the same TFs ([@bib38]). This suggests that the activity of TFs in restricting plasticity is conserved in other systems. There is, however, a significant difference that makes the function uncovered in this work novel. Pax5(-) B lymphocytes have been shown to retain characteristics of multipotent hematopoietic progenitor Pro-B cells, making it unclear whether it is the transformation into a less differentiated cell type or the lack of Pax5 itself that makes these cells plastic ([@bib61]). In contrast, we find that terminal selector-mutant cells can retain plasticity even if they are not in a progenitor-like state. While terminal selector mutant neurons do not express neuron-type-specific genes, they clearly differentiate into a neuron-like terminal end state. They are postmitotic, still adopt a neuronal morphology, and normally activate expression of pan-neuronal features such as presynaptic vesicle machinery ([@bib9]; [@bib20]; [@bib50]; [@bib80]). Additionally, *cnd-1*, a homolog of bHLH protein NeuroD, which is expressed transiently during the progenitor-like state in cholinergic MNs, is turned off normally in an *unc-3* mutant ([@bib37]; [@bib50]). Moreover, mutant neurons of most terminal selectors tested in this assay do not even show a complete loss of expression of terminal identity genes. In *lin-11* mutants, for instance, expression of various terminal identity genes is reduced in ASG, but most tested markers are not completely eliminated ([@bib73]). Similarly, in *ttx-1* mutant AFD neurons, the expression of the glutamate transporter is off in only \~20% of neurons, while in a *ceh-14; ttx-1* double mutant it is off or dim in \~80% of neurons ([@bib76]). However, the *gcy-5^fosmid^::gfp* locus is amenable to CHE-1 activation in both the *ttx-1* single and *ttx-1;ceh-14* double mutants to a similar extent. And finally, in the hypomorphic *unc-3::mNG::AID* allele generated in this work, the cholinergic MNs seem to express cholinergic markers and move like wildtype worms suggesting that the differentiation of these cells is minimally affected. Yet, the response to CHE-1 activity in this allele is indistinguishable from the *unc-3* null allele in which MNs are entirely dysfunctional. Hence, the loss of a terminal selector does not simply eliminate the differentiated state, rendering cells more plastic by default. Rather, terminal selectors trigger plasticity restriction by a pathway that can be partially decoupled from identity acquisition.

Earlier acting selector genes of organ identity do not restrict cellular plasticity, as exemplified by the *C. elegans* pharyngeal organ selector *pha-4* ([@bib89]). This is in accordance with these earlier acting selector genes exerting their activity when cells still divide and have not yet acquired a stable and terminal identity.

Possible mechanism of action of terminal selectors in restricting plasticity {#s3-2}
----------------------------------------------------------------------------

In all terminal selector mutants tested, CHE-1 activates ASE-identity genes in only about 30% of affected neurons. This suggests that restriction of cellular plasticity also requires input from terminal selector-independent factors. In the case of *unc-3* dependent cholinergic neurons, the removal of both an H3K27 methyltransferase, *mes-2*, and an H3K9 methyltransferase, *met-2*, results in the *gcy-5^prom^::gfp* locus being more accessible to CHE-1. We find that *unc-3* and *mes-2* show an additive phenotype, suggesting that in these neurons, H3K27me3 is one of the terminal selector-independent mechanisms that contribute to restriction of cellular plasticity. On the other hand, a *met-2; unc-3* double mutant phenocopies *unc-3*, suggesting that the incorrect distribution of H3K9 methylation could be a downstream effect of *unc-3* function. This is congruent with the finding that *unc-3* mutants display an expansion of the chromatin structure of a *gcy-5* transgenic reporter.

The role of H3K27me3 in restricting plasticity has been well studied in the *C. elegans* embryo and the germline ([@bib22]; [@bib65]). However, as overall levels of H3K27me3 do not seem to be affected in somatic cells of L4 stage *mes-2* mutants ([@bib5]), this would suggest that the lack or incorrect distribution of H3K27me3 in early stages of larval development is sufficient to interfere with restriction. H3K9me3 has been reported to function in preventing iPSC conversion of fibroblasts ([@bib4]). However, in *C. elegans*, somatic developmental defects have not yet been observed in H3K9 methyltransferase mutants ([@bib92]). The current discovery that *met-2* and the homologs of HP1 function to restrict plasticity highlights the utility of TF overexpression assays in uncovering mechanisms of development.

How terminal selectors might modulate chromatin compaction remains unresolved. In cholinergic MNs there is no obvious difference in the gross, overall levels of H3K9me3 between wildtype and *unc-3* mutants. *unc-3* does not seem to be playing a significant role in activating the expression of the *met-2* or *hpl-1/2* genes. Moreover, *unc-3* does not appear to regulate the distribution of H3K9me3 marks indirectly by controlling the deposition of positive marks (H3K4me3 and H3K36me3) at genes that it transcriptionally activates, since we find that the loss of enzymes that generate these marks does not promote cellular plasticity.

Collectively, our data indicate that during identity specification, terminal selectors trigger a 'surveillance mechanism' which silences non-expressed, non-identity-specific genes. Genetic epistasis experiments suggest that this surveillance mechanism is (a) likely to be mediated by *met-2* and *hpl-1/2* and (b) carried out by the correct deposition of H3K9me on genes that are not activated in a given neuron type. This hypothesis can be tested in the future by performing cell-type-specific ChIP-seq experiments to determine the distribution of H3K9me3 in wild-type and terminal selector mutant neurons. How terminal selectors may modulate the deposition of chromatin marks remains to be discovered. One possibility is that terminal selectors directly activate target genes that define a specific neuronal identity while also directly silencing genes that are normally not expressed in the respective neuron type. Although some TFs can act as both activator and repressor depending upon the presence of other co-factors ([@bib44]; [@bib72]), we disfavor this model because it implies that to be kept in a 'non-activatable' state, all genes would need a unique terminal selector response element for every cell type that they are not expressed in. This mechanism implies an unreasonably complex gene regulatory architecture involving an exceptional number of *cis*-regulatory elements. We rather favor at this point a model in which (a) heterochromatin forms, perhaps by default mechanisms, on loci that are not activated during cellular differentiation and (b) *unc-3* regulates the expression or function of some of the proteins that organize the heterochromatic state ([Figure 7](#fig7){ref-type="fig"}). These organizers may be broadly expressed heterochromatin regulators that are 'plugged' into cell-specific differentiation program via their activation by cell-specific terminal selectors. Such regulatory linkage would provide a checkpoint to coordinate the induction of cellular differentiation programs with the loss of cellular plasticity.

Materials and methods {#s4}
=====================

Worm methods and strains {#s4-1}
------------------------

All strains were maintained using standard protocols. For heatshock experiments, worms were grown at 15°C, heatshocked at 32°C for 30 min, left at 20°C overnight and scored about 24 hr later.

### Strains {#s4-1-1}

OH9846: *otIs305 \[hsp16-41^prom^::che-1::: :3XHA::BLRP; rol-6(su1006)\]; ntIs1 \[gcy-5::gfp; lin-15b(+)\]*

OtTi6: *hsp16-41^prom^::che-1::2xFLAG* (miniMos single copy insertion)

OH13139: *otIs587 \[gcy-5^fosmid^::sl2::1xnlsgfp; ttx-3^prom^::mcherry\]*

OH13102: *otIs586 \[gcy-6^fosmid^::sl2::1xnlsgfp; ttx-3^prom^::mcherry\]*

OH13984: *ot835 (gcy-5::sl2::1xnls::mNeonGreen)* CRISPR engineered into the genome

OH14049: *otIs629 \[gcy-7^prom^::tagrfp; ttx-3^prom^::gfp\]; ntIs1\[gcy-5^prom^::GFP\]*

OH13099: *otIs583 \[gcy-5^prom306bp4XASE^::gfp; ttx-3^prom^::mcherry\]*

OH14218*: otEx6597 \[ric-19^prom^::che-1; myo-2^prom^::bfp\]*

OH14219: *otEx6598 \[unc-47^prom^::che-1; myo-2^prom^::bfp\]*

OH11979: *otEx5430 \[ift-20^prom^::che-1; rol-6(d)\]*

OH8882: *otEx3909 \[ceh-36^fosmid^::yfp\]*

OH10689: *otis355 \[rab-3^prom^::nlstagrfp\]*

OH10598: *otis348 \[unc-47^prom^::mchopti; pha-1\]*

OH11124: *otis388 \[eat-4^fosmid^::yfp::h2b\]*

OH13988: ieSi57 \[Peft-3::TIR1::mRuby:;unc-54 3'UTR\] II; *ot837(unc-3::mNeonGreen::AID)* protein tag CRISPR engineered into the genome

OH14021: *ot841* (*hpl-1::mKate2*) protein tag CRISPR engineered into the genome

OH14220: *ot860* (*hpl-2:: mKate2*) protein tag CRISPR engineered into the genome

OH14221: *ot861* (*met-2:: mKate2*) protein tag CRISPR engineered into the genome

OH12738: *otIs545 \[gcy-5^prom^::rfp; LacO repeats\]; otIs593 \[let-858^prom^::gfp::LacI; ttx-3^prom^::mcherry\]*

OH11744: *otis445 \[ace-2^prom^::rfp; LacO repeats;\] gwIs39 \[baf-1^prom^::gfp::lacI; vit-5^prom^::gfp\]*

### Mutant alleles {#s4-1-2}

unc-3(e151), ceh-14(ch3), lin-11(n389), unc-30(e191), unc-42(e419), ets-5(tm1734), ttx-1(p797), met-2(ok2307), set-25(n5021), hpl-1(tm1489), hpl-2(n4317), unc-55(e402), unc-4(e120), mab-9(gk396730), SS186: (mes-2(bn11) unc-4(e120)/mnC1 dpy-10(e128) unc-52(e444)II)

MiniMos {#s4-2}
-------

MiniMos was performed exactly as presented in [@bib25]. *hsp16.41^prom^::che-1::2Xflag* was cloned into the miniMOS vector pCFJ910 and integrated into the genome. Three independent insertions were obtained of which OTti6 was used for all experiments.

CRISPR alleles {#s4-3}
--------------

CRISPR engineering was performed exactly as described in [@bib15]. For *gcy-5,* SL2::1XNLS::mNeonGreen was inserted after the stop codon of *gcy-5*. For *unc-3,* mNeonGreen::AID tag was inserted into the C-terminus of the protein just before the stop codon. For *hpl-1*, mKate2 was inserted into the protein after the 12th amino acid. This tag was based on a published hpl-1 protein fusion ([@bib13]). For *hpl-2*, mKate2 was inserted into the protein after the 96th amino acid. This tag was based on a published *hpl-1* protein fusion ([@bib13]). There are two isoforms of *hpl-2*, both are tagged in this allele. For *met-2,* mKate2 was added to the C-terminus of the protein followed by a small protein bridge present in the plasmids published in [@bib15]. The start codon of *met-2* was kept intact. The MET-2 protein seems to localize inside the nucleus in opposition to a previously published expression pattern ([@bib82]).

Fosmid recombineering {#s4-4}
---------------------

Fosmid recombineering to create *otIs586* and *otIs587* was performed as in [@bib83]. The recombineered fosmids were linearized and injected into hermaphrodites as complex arrays with 15 ng/[µ]{.ul}l of the linearized fosmid, 3 ng/[µ]{.ul}l of *ttx-3^prom^::mcherry* used as a co-injection marker and 100 ng/[µ]{.ul}l of digested bacterial genomic DNA. Extrachromosomal lines acquired after injection were integrated into the genome using gamma irradiation.

LacO arrays {#s4-5}
-----------

To create the *gcy-5* LacO arrays, 10 ng/[µ]{.ul}l of PCR product containing *gcy-5^prom^::rfp* were injected with 2 ng/[µ]{.ul}l of LacO repeats acquired by digesting out the10 kb Sph1/Kpn1 fragment from lacO multimeric plasmid pSV2-dhfr- 8.23, and 100 ng/[µ]{.ul}l of digested bacterial genomic DNA were injected into GW396 young adult hermaphrodites. Extrachromosomal arrays that formed nuclear LacI::GFP spots were chosen for integration with gamma irradiation. Integrants that showed nuclear spots were then chosen.

The *ace-2* LacO arrays were similarly built. The injection mix contained: 10 ng/[µ]{.ul}l of *ace-2^prom^::rfp* PCR, 2 ng/[µ]{.ul}l of LacO repeats, 2 ng/[µ]{.ul}l of *elt-2::nlsdsred*, and 86 ng/[µ]{.ul}l of digested bacterial genomic DNA. Extrachromosomal and integrant lines were chosen as with *gcy-5*.

DiI filling {#s4-6}
-----------

The amphid sensory neurons of worms can uptake fluorescent dyes ([@bib77]). DiI labeling was performed by washing worms into 1 mL of M9 butter containing 1:500 dilution of DiI. Worms were left to incubate with the dye for 1 hr at room temperature, washed three times with M9 and placed on NGM plates with *E. coli* for \>1 hr to recover before imaging.

Antibody staining {#s4-7}
-----------------

A modified version of the protocol published in [@bib29] was used for GFP and H3K27me3 staining. Worms were fixed in 4% paraformaldehyde/PBS for 15 min at 4°C, washed three times in 0.5% triton/PBS, rocked gently in 5% β-mercaptoethanol/1% Triton X-100/0.1 M Tris-HCl(pH 7.5) for 18 hr at 37°C, washed four times in 1% Triton X-100/0.1 M Tris-HCl(pH7.5) and once in 1 mM CaCl~2~/1% Triton X-100/0.1 M Tris-HCl(pH7.5). A worm pellet of 20--50 μL was then shaken in 1 mg/mL of collagenase type IV (C5138, Sigma)/1 mM CaCl~2~/1% Triton X-100/0.1 M Tris-HCl(pH7.5) at 37°C for 30 min. The worms were then washed three times in PBS/0.5% Triton X-100, blocked, and stained. Blocking was done in PBS/0.2% gelatin/0.25% Triton for 30 min at room temperature. Antibodies were diluted in PBS/0.1% gelatin/0.25% Triton. Primary antibody was left on overnight at 4°C or 1 hr at room temperature and secondary antibody was applied for 3 hr at room temperature. After washing off the secondary antibody, worms were incubated with DAPI for 15 min, washed again and mounted on glass slides. Primary antibodies used were: H3K27me3 (Millipore, 1:500) and GFP (Invitrogen, 1:1000 dilution). All secondary antibodies were Alexa Flour dyes used at 1:1000 dilution.

For H3K9me3 staining, we found that anti-H3K9me3 (Abcam,1:500 dilution) showed non-specific staining as observed by the presence of staining in *met-2; set-25* embryos and L1s, which have been shown by Mass Spectroscopy to not have any H3K9me3 ([@bib82]). We found the Kimura H3K9me3 antibody, CMA318 purchased from MBL International, to be specific. For this antibody, the paraformaldehyde fixation described above did not work in somatic cells and a freeze crack antibody staining protocol on whole worms was used ([@bib16]). Worms were washed, suspended in 0.025% glutaraldehyde/ddH~2~0 and spread out in between two frost-resistant glass slides. These slides were frozen on dry ice and cracked open to break the cuticle of the animals. Freeze cracked worms were fixed in ice-cold acetone for 5 min and then in ice-cold methanol for 5 min. The worms were then washed off the slides in PBS, blocked, stained, and mounted as above.

Microscopy {#s4-8}
----------

µManager and Zen were used for image acquisition and processing ([@bib17]).

Single molecule fluorescent in situ hybridization (smFISH) {#s4-9}
----------------------------------------------------------

smFISH was performed using Custom Stellaris FISH probes, purchased from Biosearch Technologies. Staining was performed according to the manufacturer\'s protocol.
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Thank you for submitting your article \"Coordinated control of terminal differentiation and restriction of cellular plasticity\" for consideration by *eLife*. Your article has been favorably evaluated by K VijayRaghavan (Senior Editor) and three reviewers, one of whom, Kang Shen (Reviewer \#1), is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Patel and Hobert tested the relationship between cellular differentiation and cellular plasticity. They performed thorough and elegant experiments using the *C. elegans* TF *che-1*. They found that expression of *che-1* induces ectopic expression of neuronal specific genes, but only in young animals. This restriction is lost in multiple but not all selector mutants. They further showed that chromatin compaction is affected in the selector mutants. While the direct link between the selector genes and chromatin state is not clear, this exciting manuscript produced important insights into the mechanistic link between differentiation and restriction of plasticity.

Essential revisions:

1\) In [Figure 1D](#fig1){ref-type="fig"}, the authors used an artificial construct with 4XASE-GFP to show that adult heatshock of *che-1* is still able to produce transcriptionally active CHE-1. However, this assay uses an overexpressed, 4X transgene. Why not just tag the *hs-che-1* with mcherry? That should provide a direct measure of the level of expression achieved by heatshocking at different stages. Since this is a very important manipulation for the paper, I suggest that the authors do this experiment.

2\) What could the difference between the five terminal selectors that are required for restricting plasticity and the two that are not? Is it because there\'s a fate transformation in the latter group, so that another terminal selector is expressed? Or perhaps the degree of lineage separation from ASE?

3\) I find the result intriguing where ectopic expression of CHE-1 in hypoderm and muscle in the embryo could induce *gcy-5* expression. These tissues are separated from neuronal fate very early in embryogenesis. Supposedly, layers of fate restriction would have piled on by the time of terminal differentiation (e.g., the studies cited in the third paragraph of Introduction). Would this imply that terminal differentiation triggers a different kind and qualitatively stronger restriction? If so, it would enhance the interpretation of the main results: the requirement of the examined terminal selectors is not simply a result of neuronal subtypes being specified late from a generic neuronal fate. If the authors so wish, it would be interesting to see if non-neuronal genes (e.g., muscle) can be expressed easier in *unc-3* mutants than in the WT.

4\) The last paragraph of the Discussion considers possible mechanisms to explain this conundrum but the suggested alternatives seem baroque and difficult to follow. Perhaps this section can be clarified by careful editing.

5\) Of greater concern is the absence of direct evidence that a \"terminal selector\" transcription factor (UNC-3 in this case) prevents ectopic gene induction by triggering the local application of H3K9 methylation marks to silence transcription. Although the authors perform a convincing genetic epistasis experiment to confirm that the H3K9 modifying enzyme met-2 functions in the *unc-3* pathway to restrict \"cellular plasticity,\" this experiment does not rule out the possibility that the *met-2* gene product could also affect gene expression by other means. Moreover, immunostaining did not detect a quantitative difference in H3K9me levels in wildtype vs. *unc-3* mutant neurons. The authors suggest that *unc-3* may affect the distribution of H3K9me marks but not the overall level. This explanation seems plausible but is not directly tested. What is needed here is an experiment to ask if H3K9me marks are specifically applied to off target genes (i.e., not directly *unc-3* regulated) in neurons that express UNC-3. A ChIP-seq experiment that specifically interrogates genes in the UNC-3-expressing neurons could resolve this question but this set up may not be technically feasible. Have the authors considered other alternative strategies for tackling this question? At the very least, this technical caveat should be directly addressed in the text.
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Author response

*Essential revisions:*

*1) In [Figure 1D](#fig1){ref-type="fig"}, the authors used an artificial construct with 4XASE-GFP to show that adult heatshock of che-1 is still able to produce transcriptionally active CHE-1. However, this assay uses an overexpressed, 4X transgene. Why not just tag the hs-che-1 with mcherry? That should provide a direct measure of the level of expression achieved by heatshocking at different stages. Since this is a very important manipulation for the paper, I suggest that the authors do this experiment.*

The heatshock *che-1* construct used in this assay is HA-tagged, and therefore can be detected by staining. We have confirmed the presence of the heatshock induced CHE-1 by both staining for HA and by performing smFISH of *che-1*mRNA. These figures have now been added in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}. The utility of the 4XASE-GFP is in showing not only that the CHE-1 protein is expressed in response to heatshock at all stages, but also in confirming that the expressed CHE-1 protein is active as a transcription factor. This clarification has now been added to the text.

*2) What could the difference between the five terminal selectors that are required for restricting plasticity and the two that are not? Is it because there\'s a fate transformation in the latter group, so that another terminal selector is expressed? Or perhaps the degree of lineage separation from ASE?*

This is indeed interesting to consider -- there is no evidence, as far as we know, that the GABA-ergic neurons and the ASH differentiate into another cell fate in *unc-30* and *unc-42* mutants respectively (in which *che-1* is not able to reprogram identity). Additionally, lineage separation also does not explain the discrepancy as *unc-3* dependent cholinergic motor neurons are lineally very closely related to the GABA-ergic motor neurons and equally distant from *che-1* dependent ASE neurons. Another explanation for the difference could reside in the properties of the transcription factors themselves -- however, we did not find any differences in the protein domains in the transcription factors that do and do not regulate plasticity. A broader understanding of the functions of these transcription factors, such an assessment of gene expression in wt vs. mutant neurons, might be required to answer this question. There is evidence that both *unc-42* and *unc-30* work with co-factors to specify their respective neuronal fates. It is also possible that these co-factor transcription factors control cellular plasticity in these cells. These points are now briefly raised in the Discussion.

*3) I find the result intriguing where ectopic expression of CHE-1 in hypoderm and muscle in the embryo could induce gcy-5 expression. These tissues are separated from neuronal fate very early in embryogenesis. Supposedly, layers of fate restriction would have piled on by the time of terminal differentiation (e.g., the studies cited in the third paragraph of Introduction). Would this imply that terminal differentiation triggers a different kind and qualitatively stronger restriction? If so, it would enhance the interpretation of the main results: the requirement of the examined terminal selectors is not simply a result of neuronal subtypes being specified late from a generic neuronal fate. If the authors so wish, it would be interesting to see if non-neuronal genes (e.g., muscle) can be expressed easier in unc-3 mutants than in the WT.*

We did try this experiment, i.e., we expressed *hlh-1* in wt and *unc-3* mutants. However, we did not see the ectopic induction of an *unc-97* reporter in either wt or *unc-3* mutants at any larval stages. Based on these results alone though, we cannot conclude that in *unc-3* mutant neurons muscle genes are not accessible for activation. The inability of *hlh-1* to activate *unc-97* might simply suggest that *hlh-1* is insufficient for the activation of *unc-97* and may require co-factors. There is evidence that *hlh-1* works together with *unc-120* and *hnd-1* to activate muscle genes, supporting the hypothesis that it may not be sufficient in larval somatic tissues to activate *unc-97*. This would be analogous to the inability of *che-1* to activate ASEL genes *gcy-6* and *gcy-7* in all somatic larval tissues. We think that this caveat makes the results from this experiment inconclusive and therefore did not include them.

*4) The last paragraph of the Discussion considers possible mechanisms to explain this conundrum but the suggested alternatives seem baroque and difficult to follow. Perhaps this section can be clarified by careful editing.*

This paragraph has now been edited.

*5) Of greater concern is the absence of direct evidence that a \"terminal selector\" transcription factor (UNC-3 in this case) prevents ectopic gene induction by triggering the local application of H3K9 methylation marks to silence transcription. Although the authors perform a convincing genetic epistasis experiment to confirm that the H3K9 modifying enzyme met-2 functions in the unc-3 pathway to restrict \"cellular plasticity,\" this experiment does not rule out the possibility that the met-2 gene product could also affect gene expression by other means. Moreover, immunostaining did not detect a quantitative difference in H3K9me levels in wildtype vs. unc-3 mutant neurons. The authors suggest that unc-3 may affect the distribution of H3K9me marks but not the overall level. This explanation seems plausible but is not directly tested. What is needed here is an experiment to ask if H3K9me marks are specifically applied to off target genes (i.e., not directly unc-3 regulated) in neurons that express UNC-3. A ChIP-seq experiment that specifically interrogates genes in the UNC-3-expressing neurons could resolve this question but this set up may not be technically feasible. Have the authors considered other alternative strategies for tackling this question? At the very least, this technical caveat should be directly addressed in the text.*

Yes, a cell-specific ChIP-seq would be the ideal experiment, however it is technically challenging. In the absence of this, we did try to use the *gcy-5 lacI/O* array to address this question. Specifically, we asked if the localization of H3K9me3, HPL-2, HPL-1 or MET-2 changes at the *gcy-5* LacI/LacO transgenic locus in wt vs. *unc-3* mutant neurons. This, however, also proved technically unreliable for the following reasons: For detecting H3K9me3, we performed immunostaining and tried to ask if the colocalization between the LACI::GFP (bound at the *gcy-5 LacO* locus) and H3K9me3 changes in wt and *unc-3* mutants. However, this staining procedure required an acetone/methanol fixation, which did not preserve the chromatin architecture (as was obvious by comparing the *ace-2 LacO* arrays in wt and *unc-3* mutants after acetone/methanol fixation vs. live imaging or paraformaldehyde fixation), and co-staining experiments were therefore unreliable. We also tried to measure the co-localization of HPL-1/2 and MET-2 using the mKATE-2 tagged CRISPR alleles at the *gcy-5 LacI/O* locus, but could not reliably image fluorescence because of low expression levels in neurons. The fact that the manuscript does not show the functional relationship between *unc-3* and *met-2* mediated chromatin effects has now been further clarified by the addition of these attempted experiments and an edited Discussion.
